Does Hanesbrands’ (HBI) Index Removal Reveal Shifting Institutional Support or a Temporary Setback?

• On November 28, 2025, Hanesbrands Inc. (NYSE:HBI) was removed from several major Russell indexes, including the Russell 3000 and Russell 2000 Growth indexes.
• This widespread index exclusion often prompts forced selling by index-tracking funds, highlighting how benchmark membership can impact investor flows and company perception.
• We’ll explore how Hanesbrands’ removal from multiple indexes could influence its investment story and future institutional investor interest.

This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.

Hanesbrands Investment Narrative Recap

To be a Hanesbrands shareholder, you need to believe in the company’s ability to restore consistent growth, particularly through reinvestment in its brands, supply chain efficiency, and capturing new categories and geographies. While the recent removal from several Russell indexes may increase short-term volatility due to forced selling from index-linked funds, it does not materially affect Hanesbrands’ most important near-term catalyst: the successful completion of its pending acquisition by Gildan Activewear. The biggest risk remains Hanesbrands’ exposure to ongoing shifts in consumer preferences within its key U.S. intimates category. Among recent announcements, the approval of the company’s merger with Gildan Activewear stands out as the most relevant development. This corporate event is expected to become the central driver of Hanesbrands’ future strategic direction, potentially outweighing the impact of index exclusion and supporting the business catalyst of expanded scale, reach, and resources. The market’s focus is likely to remain on whether the merger delivers value and operational improvements as anticipated. In contrast, investors should also be aware that Hanesbrands’ vulnerability to rapid shifts in consumer trends could...

Read the full narrative on Hanesbrands (it's free!)

Hanesbrands' narrative projects $3.6 billion in revenue and $274.0 million in earnings by 2028. This requires a 0.4% yearly revenue decline and a $104.0 million earnings increase from current earnings of $170.0 million.

Uncover how Hanesbrands' forecasts yield a $6.55 fair value, in line with its current price.

Exploring Other Perspectives

Simply Wall St Community members provided three fair value estimates for Hanesbrands, ranging from US$6.39 to US$8.03 per share. While these views cover a broad spectrum, ongoing shifts in consumer preferences and private label competition add uncertainty to the company’s outlook, encouraging you to consider alternative viewpoints.

Explore 3 other fair value estimates on Hanesbrands - why the stock might be worth as much as 24% more than the current price!

Build Your Own Hanesbrands Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Hanesbrands research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Hanesbrands research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hanesbrands' overall financial health at a glance.

Searching For A Fresh Perspective?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com